Douglas K. Bratton, 10% Owner at Juno Therapeutics, Inc. (JUNO), sold 1,095,726 shares at $50.92 ($13.8M) on 2015-06-23, disclosed to the SEC on 2015-06-25.
Open-market sale of $13.8M JUNO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 825,726 | $0 | 0.0% |
| 2 | $50.92 | 135,000 | $6.9M | 49.8% |
| 3 | $51.33 | 135,000 | $6.9M | 50.2% |
| Total | $12.60 avg | 1,095,726 | $13.8M | 100% |
| Filing → |
| DNLI | BUY | 2017-12-14 | $5.0M | — | Filing → |
| JUNO | SELL | 2015-07-02 | $2.2M | — | Filing → |
| JUNO | BUY | 2014-12-24 | $15.0M | — | Filing → |